Abstract
Knowledge of the effectiveness of cardioprotective medication in women with suspected ischemia is hampered by limited clinical trial data and heterogeneous risk. We assessed the effectiveness of cardioprotective medical treatment in women while adjusting for disease severity determined by cardiovascular magnetic resonance imaging (CMRI).
Highlights
Knowledge of the effectiveness of cardioprotective medication in women with suspected ischemia is hampered by limited clinical trial data and heterogeneous risk
We assessed the effectiveness of cardioprotective medical treatment in women while adjusting for disease severity determined by cardiovascular magnetic resonance imaging (CMRI)
Ischemic heart disease stratification predicted adverse cardiac events and the medication combination of a BB or CCA and no nitrate were independently associated with reduced risk of events
Summary
Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women’s ischemia synrome evaluation (WISE) study. Mark Doyle1*, Gerald Pohost, Lesliee Shaw, Sheryl Kelsey, Diane Vido, Delia Johnson, William J Rogers, William J Rogers, Geetha Rayarao, Barry Sharaf, Carl J Pepine, C Noel Bairey Merz, Robert WW Biederman. From 2011 SCMR/Euro CMR Joint Scientific Sessions Nice, France. From 2011 SCMR/Euro CMR Joint Scientific Sessions Nice, France. 3-6 February 2011
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
